Lovastatin Tablet
Product Images NDC 61442-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 61442-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carlsbad Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg 100ct

10mg 100ct
This is a description for Lovastatin Tablets which are prescription only drugs. Each tablet contains 10mg of Lovastatin. The recommended dosage is not available as it requests to see the accompanying literature. Lovastatin Tablets should be dispensed in a tightly sealed container that is light-resistant, and stored at a temperature between 20°C to 25°C (68°F to 77°F) to protect it from the light. The lot number of the drug is NDC 61442-141-01, and they are manufactured by Carevaa Technology.*
FDA Label Image

20mg 100ct

20mg 100ct
This text is a pharmaceutical label with information on a medicine. It contains the National Drug Code (NDC) number, dosage, and storage information. The medicine includes Lovastatin, and is dispensed with a prescription. The tablets come in a container that meets the USP standards, and should be stored at a controlled room temperature, away from light. The label belongs to a company named "Carisbad Technology".*
FDA Label Image

40mg 100ct

40mg 100ct
This is a description of a medication. The NDC number is 61442-143-01 and it contains 100 tablets. Each tablet contains 40g of Lovastatin which is a medication used for lowering cholesterol. The medication is USP approved and should be kept at a cool temperature and protected from light. Rx only.*
FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
This is a figure showing the proportion of participants without acute major coronary events as the primary endpoint over the course of four years of follow-up. No further information is available.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
This text appears to be a table with information on drug interactions that increase the risk of myopathy or rhabdomyolysis. It includes a list of prescribing recommendations for certain medications and drugs to avoid or use with caution when taking lovastatin. Specifically, the table notes that certain medications like strong CYP3A4 inhibitors, HIV protease inhibitors, and cobicistat-containing products are contraindicated with lovastatin. Additionally, gemfibrozil should be avoided when taking lovastatin, and cyclosporine, danazol, diltiazem, and dronedarone may increase the risk of myopathy/rhabdomyolysis when taken with lovastatin. The table also recommends not exceeding certain daily doses of lovastatin and avoiding grapefruit juice.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.